Suppliers / Jiangsu Zw Pharmaceuticals

Jiangsu Zw Pharmaceuticals

China Updated 9 July 2026

Jiangsu Zw Pharmaceuticals is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Sulindac US FDA 1
Zopiclone US FDA 1

Also appears on these molecule pages

Sulindac API Zopiclone API

Questions about Jiangsu Zw Pharmaceuticals

Does Jiangsu Zw Pharmaceuticals hold a US DMF or a CEP?
Jiangsu Zw Pharmaceuticals holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangsu Zw Pharmaceuticals make?
2 molecules are on record against Jiangsu Zw Pharmaceuticals, including Sulindac and Zopiclone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Zw Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 1 molecule Olon shares 1 molecule Jubilant Biosys shares 1 molecule Piramal Pharma shares 1 molecule Industriale Chimica shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability